<DOC>
	<DOCNO>NCT02203955</DOCNO>
	<brief_summary>The main objective compare prebiotic therapy placebo prevention pouchitis closure divert ileostomy patient ileal pouch anal anastomosis . This study also characterize effect prebiotics fecal microbiota fecal microbial metabolite correlate effect primary outcome development pouchitis .</brief_summary>
	<brief_title>Study Sc-FOS Pouchitis Prevention</brief_title>
	<detailed_description />
	<mesh_term>Pouchitis</mesh_term>
	<criteria>Inclusion criterion : 1 . Age 1865 year . 2 . History ulcerative colitis 3 . Ileostomy closure IPAA 4 . Ability give appropriate consent 1 . Crohn 's disease . 2 . Perianal disease ( include abscess , fissure , stricture ) 3 . Pregnancy 4 . Lactation 5 . Concurrent treatment IBD pouchitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>